These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12881310)

  • 41. Dynamics of urokinase receptor interaction with Peptide antagonists studied by amide hydrogen exchange and mass spectrometry.
    Jørgensen TJ; Gårdsvoll H; Danø K; Roepstorff P; Ploug M
    Biochemistry; 2004 Nov; 43(47):15044-57. PubMed ID: 15554712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile.
    Murciano JC; Higazi AA; Cines DB; Muzykantov VR
    J Control Release; 2009 Nov; 139(3):190-6. PubMed ID: 19616049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence.
    Liang OD; Chavakis T; Linder M; Bdeir K; Kuo A; Preissner KT
    Biol Chem; 2003 Feb; 384(2):229-36. PubMed ID: 12675515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant toxins that bind to the urokinase receptor are cytotoxic without requiring binding to the alpha(2)-macroglobulin receptor.
    Rajagopal V; Kreitman RJ
    J Biol Chem; 2000 Mar; 275(11):7566-73. PubMed ID: 10713063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
    Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
    Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
    Sun Z; Zhang PX; Wang P; Gurewich V; Shen HY; Liu JN
    Thromb Res; 2002 Apr; 106(2):105-11. PubMed ID: 12182908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A; Castellino FJ
    Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor.
    Ploug M; Ellis V; Danø K
    Biochemistry; 1994 Aug; 33(30):8991-7. PubMed ID: 8043585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor.
    Mahdi F; Shariat-Madar Z; Kuo A; Carinato M; Cines DB; Schmaier AH
    J Biol Chem; 2004 Apr; 279(16):16621-8. PubMed ID: 14764580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
    DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains.
    Poliakov AA; Mukhina SA; Traktouev DO; Bibilashvily RS; Gursky YG; Minashkin MM; Stepanova VV; Tkachuk VA
    J Recept Signal Transduct Res; 1999 Nov; 19(6):939-51. PubMed ID: 10533982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crystal structure of the urokinase receptor in a ligand-free form.
    Xu X; Gårdsvoll H; Yuan C; Lin L; Ploug M; Huang M
    J Mol Biol; 2012 Mar; 416(5):629-41. PubMed ID: 22285761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase.
    Corti A; Sarubbi E; Soffientini A; Nolli ML; Zanni A; Galimberti M; Parenti F; Cassani G
    Thromb Haemost; 1989 Nov; 62(3):934-9. PubMed ID: 2480654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
    Rasch MG; Pass J; Illemann M; Høyer-Hansen G; Lund IK
    J Immunol Methods; 2008 Nov; 339(1):55-65. PubMed ID: 18761343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.
    Rettenberger P; Wilhelm O; Oi H; Weidle UH; Goretzki L; Koppitz M; Lottspeich F; König B; Pessara U; Kramer MD
    Biol Chem Hoppe Seyler; 1995 Oct; 376(10):587-94. PubMed ID: 8590627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of single chain urokinase by small peptides.
    Higazi A al-R ; Cines D
    Thromb Res; 1996 Nov; 84(4):243-52. PubMed ID: 8948049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.
    Resnati M; Guttinger M; Valcamonica S; Sidenius N; Blasi F; Fazioli F
    EMBO J; 1996 Apr; 15(7):1572-82. PubMed ID: 8612581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites.
    Gårdsvoll H; Werner F; Søndergaard L; Danø K; Ploug M
    Protein Expr Purif; 2004 Apr; 34(2):284-95. PubMed ID: 15003263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer.
    Mazar AP
    Anticancer Drugs; 2001 Jun; 12(5):387-400. PubMed ID: 11395568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.
    Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ
    Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.